Company news
Cnbx Pharmaceuticals Inc. (OTC:CNBX) news
Cnbx Pharmaceuticals Inc. news releases on 6ix. Latest, Aug 9, 2018: Join Cannabics Pharmaceuticals at the MJBizCon Held at Metro Toronto Convention Center…
Press releases — page 3
Join Cannabics Pharmaceuticals at the MJBizCon Held at Metro Toronto Convention Center, Toronto, August 14-16, 2018
August 9, 2018
Cannabics Pharmaceuticals' CEO Issues Letter to Shareholders
August 2, 2018
Join Cannabics Pharmaceuticals at the National Cannabis Industry Association's Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018
July 11, 2018
Cannabics Pharmaceuticals Announces Conclusion of Clinical Trial on Cannabics SR 5mg for Cancer Anorexia Cachexia Syndrome (CACS)
July 3, 2018
Cannabics Pharmaceuticals Enters a Memorandum of Understanding With Clinical-Stage Biopharmaceutical Company Focused on the Treatment of Ophthalmic Disorders
June 29, 2018
Cannabics Pharmaceuticals to Participate in the International Cannabis Research Society Annual Forum in Leiden, the Netherlands
June 26, 2018
Join Cannabics Pharmaceuticals at LCBC Cannabis Professional Conference Held at MTCC, Toronto, Canada, May 25-27, 2018
May 24, 2018
Cannabics Pharmaceuticals Hires Two New Scientists to Further Develop Cannabinoid Diagnostic Tests and Treatments for Cancer
May 22, 2018
Cannabics Pharmaceuticals Announces Collaboration With Life Source Partners CEO Muriel Zohar to Optimize Technology Applications and Evaluate New Opportunities
May 2, 2018
Cannabics Pharmaceuticals Announces New Technology Patent
April 18, 2018
Cannabics Pharmaceuticals Receives Positive Results From Preclinical Study on Antitumor Effects of Cannabinoids
March 29, 2018
Cannabics' Dr. Moran Grinberg to Speak at the Annual CannaTech Conference
February 28, 2018
Cannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application
February 20, 2018
Cannabics Pharmaceuticals Files an International Patent Application on Methods for Testing and Predicting Therapeutic Effectiveness of Cannabinoids for Cancer Patients
January 2, 2018
Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids
November 28, 2017
Cannabics Pharmaceuticals Files Patent Application on Cannabinoid Modulation of the Microbiome
November 8, 2017
Cannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells
September 25, 2017
Cannabics Pharmaceuticals Files a Patent Application for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs
September 6, 2017
Cannabics Pharmaceuticals Received Positive Report from The Patent Cooperation Treaty Regarding Cannabinoid Personalized Screening of Cancer Cells
August 28, 2017
Cannabics Pharmaceuticals Establishes a Human-Cannabis-Cancer Genetics lab to Expand its Personalized Diagnostics
July 24, 2017
Cannabics Pharmaceuticals Executed a Final Collaboration Agreement with SIMFO GmbH
July 12, 2017
Cannabics Pharmaceuticals Receives Positive Results in Drug Sensitivity Tests on CTCs
June 30, 2017
Cannabics Pharmaceuticals Inc. Provides Shareholders Update June 2017
June 2, 2017
Cannabics Pharmaceuticals Raises $3,000,000 in Capital Raise Transaction
May 10, 2017
Cannabics Pharmaceuticals Announces Scientific Collaboration With A Leading CTC European Lab
May 3, 2017
Cannabics Pharmaceuticals Inc. Receives the Final Report of Its Research on Antitumor Properties of Cannabinoids Held in Israel
April 3, 2017
Cannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors
March 9, 2017
Cannabics Pharmaceuticals Inc. Provides Shareholders Update Regarding Increased Volume in its Shares
February 23, 2017
Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients
February 5, 2017
Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome
January 3, 2017
Cannabics Pharmaceuticals Announces Specific Ratios of Cannabinoids Led to Apoptosis in MDA-MB-231 Breast Cancer Cell Viability
December 1, 2016
OTC Markets Group Welcomes Newly Verified OTCQB Companies – December 1
December 1, 2016
Cannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System
June 6, 2016
Cannabics Pharmaceuticals Announces Start of Clinical Study in Israel for Cancer Patients
March 22, 2016
Cannabics Pharmaceuticals Places IP & Subsidiary Within the Company
February 29, 2016
Cannabics Pharmaceuticals Files Patent Application for the Company's Slow Release Capsules
February 24, 2016
Cannabics Pharmaceuticals Inc. Announces a New Division of Labor in the Corporate Structure
October 9, 2015
Cannabics Pharmaceuticals Inc. Announces New Access of Cannabics Oil Capsules for Patients With Medical Cannabis License in Israel
September 8, 2015
Cannabics Pharmaceuticals Inc. Announces Increasing Sales of WanaCapsXR Capsules in Every Region of Colorado
August 13, 2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – August 11
August 11, 2015
Revocation of BCSC Cease Trade Order
October 21, 2013
British Columbia Securities Commission - Cease Trade Order
August 26, 2011